AstraZeneca and Merck point to progress on early-stage breast cancer

Lynparza shown to reduce recurrence rates, while Novartis to unveil new type of radiotherapy
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news